There are 594 resources available
192P - Differential effect of proton pump inhibitors (PPIs) and antibiotics (ATB) on clinical outcomes from immunotherapy or placebo in patients with locally advanced, unresectable NSCLC who have not progressed following chemoradiation therapy (cCTRT): A post-hoc analysis of the PACIFIC trial
Presenter: Leonardo Brunetti
Session: Poster Display session
193P - Association of Effective Dose to Immune Cells with Outcomes after Definitive Chemoradiotherapy and Durvalumab in Non-Small Cell Lung Cancer: A Multi-Center Study
Presenter: Ari Raphael
Session: Poster Display session
194P - Durvalumab prolongs overall survival whereas radiation dose escalation >66 Gy improves long-term local control in unresectable NSCLC stage III: Updated analysis of the Austrian radio-oncological lung cancer study association registry (ALLSTAR)
Presenter: Franz Zehentmayr
Session: Poster Display session
195P - Real-world study of patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab: Ra-pacific
Presenter: Luis Basbus
Session: Poster Display session
196P - 5-year survival and safety of stereotactic ablative radiotherapy in unresectable locally advanced non-small cell lung cancer patients unfit for concurrent radiochemotherapy: Focus on patterns of local recurrence from the START-NEW-ERA non-randomized phase II trial
Presenter: Fabio Arcidiacono
Session: Poster Display session
197P - Efficacy and safety of induction chemo-immunotherapy in unresectable stage III non-small cell lung cancer: A real-world multicenter retrospective study
Presenter: Wenlu Chen
Session: Poster Display session
Resources:
Abstract
198P - Progression patterns and survival outcomes in patients with locally advanced NSCLC after chemo-radiotherapy and durvalumab: Insights into post-progression strategies from a single institution
Presenter: Rita Leporati
Session: Poster Display session
199P - Toxicity profiles of definitive chemoradiation with and without immunotherapy
Presenter: Salma Jabbour
Session: Poster Display session
200P - The impact of COVID 19 infection in patients undergoing definitive chemoradiation for locally advanced lung cancer
Presenter: Bryce Comstock
Session: Poster Display session